We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » New Complete Response Letter for Janssen, Bayer’s Xarelto
New Complete Response Letter for Janssen, Bayer’s Xarelto
July 12, 2013
Janssen said June 28 it received another complete response letter (CRL) for a supplemental drug application regarding its anticoagulant Xarelto, although this time it’s for a separate indication.